Skip to main content
main-content
Top

Tip

Swipe om te navigeren naar een ander artikel

Gepubliceerd in: Quality of Life Research 7/2017

27-02-2017 | Brief Communication

Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study

Auteurs: Rachel Isaksson Vogel, Lori G. Strayer, Leah Engelman, Heather H. Nelson, Anne H. Blaes, Kristin E. Anderson, DeAnn Lazovich

Gepubliceerd in: Quality of Life Research | Uitgave 7/2017

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Purpose

Little is known about specific concerns facing long-term melanoma survivors. The goal of this study was to compare quality of life (QOL) and mental health between long-term melanoma survivors and population controls.

Methods

Participants from a previously conducted case-control study of risk factors for melanoma were recruited for a cross-sectional survey. Generic QOL and emotional health were measured using the SF-36 and Hospital Anxiety and Depression Scale questionnaires. A total of 724 melanoma survivors and 660 controls participated. Most melanoma survivors had stage I disease (85.6%); mean time from diagnosis was 9.6 ± 1.0 years. Comparisons of QOL measures between melanoma survivors and controls were conducted using regression models, adjusting for potential confounders.

Results

Melanoma survivors, compared to controls, reported statistically significant but only slightly higher physical functioning and bodily pain QOL subscale scores than controls and otherwise similar QOL as measured by the remaining six SF-36 subscale scores. Prevalence of anxiety (18.1% vs. 19.3%, adjusted OR = 1.00 (0.74, 1.36); p = 1.00) and depression (7.2% vs. 9.8%, adjusted OR = 0.74 (0.48, 1.16); p = 1.00) were similar between melanoma survivors and controls.

Conclusion

Long-term early stage melanoma survivors report similar general QOL and mental health compared to population controls. Further research is needed to identify concerns more specific to melanoma.

Met onderstaand(e) abonnement(en) heeft u direct toegang:

BSL Podotherapeut Totaal

Binnen de bundel kunt u gebruik maken van boeken, tijdschriften, e-learnings, web-tv's en uitlegvideo's. BSL Podotherapeut Totaal is overal toegankelijk; via uw PC, tablet of smartphone.

Literatuur
3.
go back to reference Garbe, C., & Leiter, U. (2009). Melanoma epidemiology and trends. Clinics in Dermatology, 27(1), 3–9. CrossRefPubMed Garbe, C., & Leiter, U. (2009). Melanoma epidemiology and trends. Clinics in Dermatology, 27(1), 3–9. CrossRefPubMed
4.
go back to reference Cornish, D., Holterhues, C., van de Poll-Franse, L., Coebergh, J., & Nijsten, T. (2009). A systematic review of health-related quality of life in cutaneous melanoma. Annals of Oncology, 20, 51–58. CrossRef Cornish, D., Holterhues, C., van de Poll-Franse, L., Coebergh, J., & Nijsten, T. (2009). A systematic review of health-related quality of life in cutaneous melanoma. Annals of Oncology, 20, 51–58. CrossRef
5.
go back to reference Butow, P. N., Coates, A. S., & Dunn, S. M. (1999). Psychosocial predictors of survival in metastatic melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 17(7), 2256–2263. CrossRef Butow, P. N., Coates, A. S., & Dunn, S. M. (1999). Psychosocial predictors of survival in metastatic melanoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 17(7), 2256–2263. CrossRef
6.
go back to reference Lehto, U. S., Ojanen, M., Dyba, T., Aromaa, A., & Kellokumpu-Lehtinen, P. (2007). Baseline psychosocial predictors of survival in localized melanoma. Journal of Psychosomatic Research, 63(1), 9–15. CrossRefPubMed Lehto, U. S., Ojanen, M., Dyba, T., Aromaa, A., & Kellokumpu-Lehtinen, P. (2007). Baseline psychosocial predictors of survival in localized melanoma. Journal of Psychosomatic Research, 63(1), 9–15. CrossRefPubMed
7.
go back to reference Foster, C., Wright, D., Hill, H., Hopkinson, J., & Roffe, L. (2009). Psychosocial implications of living 5 years or more following a cancer diagnosis: A systematic review of the research evidence. European Journal of Cancer Care, 18(3), 223–247. CrossRefPubMed Foster, C., Wright, D., Hill, H., Hopkinson, J., & Roffe, L. (2009). Psychosocial implications of living 5 years or more following a cancer diagnosis: A systematic review of the research evidence. European Journal of Cancer Care, 18(3), 223–247. CrossRefPubMed
8.
go back to reference Valdivieso, M., Kujawa, A. M., Jones, T., & Baker, L. H. (2012). Cancer survivors in the United States: A review of the literature and a call to action. International Journal of Medical Sciences, 9(2), 163–173. CrossRefPubMedPubMedCentral Valdivieso, M., Kujawa, A. M., Jones, T., & Baker, L. H. (2012). Cancer survivors in the United States: A review of the literature and a call to action. International Journal of Medical Sciences, 9(2), 163–173. CrossRefPubMedPubMedCentral
9.
go back to reference Kasparian, N. A., McLoone, J. K., & Butow, P. N. (2009). Psychological responses and coping strategies among patients with malignant melanoma: A systematic review of the literature. Archives of Dermatology, 145(12), 1415–1427. CrossRefPubMed Kasparian, N. A., McLoone, J. K., & Butow, P. N. (2009). Psychological responses and coping strategies among patients with malignant melanoma: A systematic review of the literature. Archives of Dermatology, 145(12), 1415–1427. CrossRefPubMed
10.
go back to reference Heinze, S., Egberts, F., Rotzer, S., Volkenandt, M., Tilgen, W., Linse, R., Boettjer, J., Vogt, T., Spieth, K., Eigentler, T., Brockmeyer, N., Hinzpeter, A., Hauschild, A., & Schaefer, M. (2010). Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma results from the multicenter DeCOG trial. Journal of Immunotherapy, 33(1), 106–114. CrossRefPubMed Heinze, S., Egberts, F., Rotzer, S., Volkenandt, M., Tilgen, W., Linse, R., Boettjer, J., Vogt, T., Spieth, K., Eigentler, T., Brockmeyer, N., Hinzpeter, A., Hauschild, A., & Schaefer, M. (2010). Depressive mood changes and psychiatric symptoms during 12-month low-dose interferon-alpha treatment in patients with malignant melanoma results from the multicenter DeCOG trial. Journal of Immunotherapy, 33(1), 106–114. CrossRefPubMed
11.
go back to reference Rataj, D., Jankowiak, B., Krajewska-Kulak, E., Van Damme-Ostapowicz, K., Nowecki, Z. I., Rutkowski, P., & Niczyporuk, W. (2005). Quality-of-life evaluation in an interferon therapy after radical surgery in cutaneous melanoma patients. Cancer Nursing, 28(3), 172–178. CrossRefPubMed Rataj, D., Jankowiak, B., Krajewska-Kulak, E., Van Damme-Ostapowicz, K., Nowecki, Z. I., Rutkowski, P., & Niczyporuk, W. (2005). Quality-of-life evaluation in an interferon therapy after radical surgery in cutaneous melanoma patients. Cancer Nursing, 28(3), 172–178. CrossRefPubMed
12.
go back to reference Dixon, S., Walters, S. J., Turner, L., & Hancock, B. W. (2006). Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: Results from randomised trial. British Journal of Cancer, 94(4), 492–498. CrossRefPubMedPubMedCentral Dixon, S., Walters, S. J., Turner, L., & Hancock, B. W. (2006). Quality of life and cost-effectiveness of interferon-alpha in malignant melanoma: Results from randomised trial. British Journal of Cancer, 94(4), 492–498. CrossRefPubMedPubMedCentral
13.
go back to reference Trask, P., Paterson, A., Esper, P., Pau, J., & Redman, B. (2004). Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psycho-Oncology, 13(8), 526–536. CrossRefPubMed Trask, P., Paterson, A., Esper, P., Pau, J., & Redman, B. (2004). Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon. Psycho-Oncology, 13(8), 526–536. CrossRefPubMed
14.
go back to reference Butow, P., Coates, A., & Dunn, S. (1999). Psychosocial predictors of survival in metastatic melanoma. Journal of Clinical Oncology, 17(7), 2256–2263. CrossRefPubMed Butow, P., Coates, A., & Dunn, S. (1999). Psychosocial predictors of survival in metastatic melanoma. Journal of Clinical Oncology, 17(7), 2256–2263. CrossRefPubMed
15.
go back to reference Brown, J., Butow, P., Culjak, G., Coates, A., & Dunn, S. (2000). Psychosocial predictors of outcome: Time to relapse and survival in patients with early stage melanoma. British Journal of Cancer, 83(11), 1448–1453. CrossRefPubMedPubMedCentral Brown, J., Butow, P., Culjak, G., Coates, A., & Dunn, S. (2000). Psychosocial predictors of outcome: Time to relapse and survival in patients with early stage melanoma. British Journal of Cancer, 83(11), 1448–1453. CrossRefPubMedPubMedCentral
16.
go back to reference Vogel, R. I., Strayer, L. G., Engelman, L., Nelson, H. H., Blaes, A. H., Anderson, K. E., & Lazovich, D. (2017). Sun exposure and protection behaviors among long-term melanoma survivors and non-cancer controls. Cancer Epidemiology, Biomarkers and Prevention. Vogel, R. I., Strayer, L. G., Engelman, L., Nelson, H. H., Blaes, A. H., Anderson, K. E., & Lazovich, D. (2017). Sun exposure and protection behaviors among long-term melanoma survivors and non-cancer controls. Cancer Epidemiology, Biomarkers and Prevention.
17.
go back to reference Lazovich, D., Vogel, R. I., Berwick, M., Weinstock, M. A., Anderson, K. E., & Warshaw, E. M. (2010). Indoor tanning and risk of melanoma: A case-control study in a highly exposed population. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 19(6), 1557–1568. CrossRef Lazovich, D., Vogel, R. I., Berwick, M., Weinstock, M. A., Anderson, K. E., & Warshaw, E. M. (2010). Indoor tanning and risk of melanoma: A case-control study in a highly exposed population. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 19(6), 1557–1568. CrossRef
18.
go back to reference Dillman, D., Smith, J., & Christian, L. (2014). Internet, phone, mail and mixed-mode surveys: The tailored design method (4th ed.). New Jersey: Wiley. Dillman, D., Smith, J., & Christian, L. (2014). Internet, phone, mail and mixed-mode surveys: The tailored design method (4th ed.). New Jersey: Wiley.
20.
go back to reference Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. CrossRefPubMed Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67(6), 361–370. CrossRefPubMed
21.
go back to reference Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the hospital anxiety and depression scale. An updated literature review. Journal of Psychosomatic Research, 52(2), 69–77. CrossRefPubMed Bjelland, I., Dahl, A. A., Haug, T. T., & Neckelmann, D. (2002). The validity of the hospital anxiety and depression scale. An updated literature review. Journal of Psychosomatic Research, 52(2), 69–77. CrossRefPubMed
22.
go back to reference Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592. PubMed Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care, 41(5), 582–592. PubMed
23.
go back to reference Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65–70. Holm, S. (1979). A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics, 6, 65–70.
24.
go back to reference Aziz, N. M. (2007). Cancer survivorship research: State of knowledge, challenges and opportunities. Acta Oncologica (Stockholm, Sweden), 46(4), 417–432. CrossRef Aziz, N. M. (2007). Cancer survivorship research: State of knowledge, challenges and opportunities. Acta Oncologica (Stockholm, Sweden), 46(4), 417–432. CrossRef
25.
go back to reference Holterhues, C., Cornish, D., van de Poll-Franse, L., Krekels, G., Koedijk, F., Kuijpers, D., Coebergh, J., & Nijsten, T. (2011). Impact of melanoma on patients’ lives among 562 survivors a Dutch population-based study. Archives of Dermatology, 147(2), 177–185. CrossRefPubMed Holterhues, C., Cornish, D., van de Poll-Franse, L., Krekels, G., Koedijk, F., Kuijpers, D., Coebergh, J., & Nijsten, T. (2011). Impact of melanoma on patients’ lives among 562 survivors a Dutch population-based study. Archives of Dermatology, 147(2), 177–185. CrossRefPubMed
Metagegevens
Titel
Comparison of quality of life among long-term melanoma survivors and non-melanoma controls: a cross-sectional study
Auteurs
Rachel Isaksson Vogel
Lori G. Strayer
Leah Engelman
Heather H. Nelson
Anne H. Blaes
Kristin E. Anderson
DeAnn Lazovich
Publicatiedatum
27-02-2017
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 7/2017
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-017-1532-6